Quek Samuel Y P, Subramanian Gayathri, Patel Jasma, Ananthan Sowmya, Zagury Julyana G, Khan Junad
Department of Diagnostic Sciences, Rutgers School of Dental Medicine , Newark, NJ, USA.
Cranio. 2015 Oct;33(4):285-90. doi: 10.1080/08869634.2015.1097300. Epub 2015 Dec 29.
To compare the efficacy of a regional masseteric nerve block (MNB) in the management of myofascial pain of masseteric origin, relative to trigger point injection (TrP-Inj) and intra-oral stabilization appliance (IOA).
A retrospective chart review of 200 patients treated for myofascial pain of masseteric origin was performed. Sixty patients met the eligibility criteria and were grouped based on their treatment regimen; IOA, TrP-Inj or MNB. Pain scores recorded at pre-treatment (baseline), 30 minutes post-treatment, and 2 weeks post-treatment were analyzed.
Treatment with MNB resulted in significant reduction in pain at 30 minutes and two weeks post-treatment compared to TrP-Inj and IOA.
MNB provided an immediate and sustained therapeutic effect for the management of myofascial pain for at least up to two weeks. MNB is a simple and valuable tool in the management of myogenous pain, especially for the non-orofacial pain practitioner.
比较区域咬肌神经阻滞(MNB)与触发点注射(TrP-Inj)及口内稳定矫治器(IOA)在治疗咬肌源性肌筋膜疼痛方面的疗效。
对200例接受咬肌源性肌筋膜疼痛治疗的患者进行回顾性病历审查。60例患者符合纳入标准,并根据其治疗方案分组;IOA、TrP-Inj或MNB。分析治疗前(基线)、治疗后30分钟和治疗后2周记录的疼痛评分。
与TrP-Inj和IOA相比,MNB治疗在治疗后30分钟和2周时疼痛显著减轻。
MNB为肌筋膜疼痛的治疗提供了即时且持续的治疗效果,至少可持续两周。MNB是治疗肌源性疼痛的一种简单且有价值的工具,尤其对于非口腔颌面疼痛科医生而言。